Intra-Cellular Therapies Inc

Common Name
Intra-Cellular Therapies
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
860
Ticker
ITCI
Exchange
NASDAQ/NGS
Description
Intra-Cellular Therapies Inc. is a biopharmaceutical company that innovates in the development of novel drugs for treating complex psychiatric and neurological disorders. Its primary focus is on treat...

Intra-Cellular Therapies Waste Data Preview

In 2023, Intra-Cellular Therapies conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Intra-Cellular Therapies's Waste Treatment Practices

In 2023, Intra-Cellular Therapies generated a total of 2 metric tonnes of waste.

Of this amount, 20% of Intra-Cellular Therapies's total waste generated was recovered through methods such as recycling, reuse, or composting, while 80% was disposed of through landfilling, incineration, or combustion.

Intra-Cellular Therapies's Waste Recovery Rate

20%

How much of Intra-Cellular Therapies's waste is recycled or recovered?

In 2023, Intra-Cellular Therapies reported a total waste generation of 2 metric tonnes, of which 20% was recovered through recycling, reuse, or composting. This low recovery rate highlights limited waste diversion and suggests that Intra-Cellular Therapies may be relying more heavily on landfill or incineration, underscoring opportunities for stronger resource recovery initiatives.

Insights into Intra-Cellular Therapies’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Intra-Cellular Therapies generated a total of 2 metric tonnes of waste.

Of this amount, 80% of Intra-Cellular Therapies's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 20% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

Want Full Access to Intra-Cellular Therapies's Waste Management Dataset?
Sign Up